Company intelligence / Profile preview
Shift Bioscience
Cambridge, Cambridgeshire, United Kingdomshiftbioscience.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Shift Bioscience has developed an advanced AI-driven platform that simulates cellular biology to rapidly identify gene interventions capable of safely reversing cellular aging. The company has validated its approach in vitro by identifying over a hundred genes affecting the biological age of cells. Preliminary results have been positively received at scientific conferences but no clinical trial data are available yet.
- Therapeutic areas
- Other
- Modalities
- Gene therapy (gene-based interventions)Small molecule drugsAI-guided cell simulation platforms for target discovery
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Academic collaborations with University of Toronto/Vector Institute via Prof. Bo Wang as Senior Advisor for machine learning/cell simulation development
Beyond the preview
Go deeper on Shift Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shift Bioscience.